Grace Therapeutics, Inc. Common Stock (NASDAQ: GRCE) last traded at $1.99, down 1.49% on the session. The quote above updates while this page is open; the figures below are drawn from Grace Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Grace Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker GRCE. Its market capitalisation is $41.86 million.
Valuation measures for Grace Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $41.86M |
|---|---|
| Enterprise value | $29.97M |
| Price / book | 0.87 |
| Beta | 0.82 |
Trailing-twelve-month figures tagged in Grace Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$20.22M |
| EPS (TTM) | -$1.17 |
|---|
| Return on equity | -41.94% |
|---|
| Cash | $13.76M |
|---|
Range and volume for GRCE over the past 52 weeks.
| 52-week high | $5.18 |
|---|---|
| 52-week low | $1.79 |
| Volume | 49.2K |
| Average volume | 165.3K |
| Previous close | $2.02 |
Invest a chosen dollar amount in Grace Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GRCE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.